Cardlytics Inc. Stock News

Cardlytics (CDLX) delivered earnings and revenue surprises of 44.93% and 3.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ATLANTA, May 02, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the first quarter ended March 31, 2022. Supplemental

Cardlytics (CDLX) delivered earnings and revenue surprises of 44.93% and 3.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Cardlytics, Inc. (NASDAQ:CDLX ) Q1 2022 Earnings Conference Call May 2, 2022 5:00 PM ET Company Participants Kirk Somers - Chief Legal & Privacy Officer Lynne Laube - Chief Executive Officer & Co-Foun

ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced the appointment of Jose Singer as its Chief Product Offic

ATLANTA, April 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that its first quarter ended March 31, 2022 financ

ATLANTA, April 19, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks' digital channels, today announced that its first quarter ended March 31, 2022 financial

Cryptocurrency exchange Crypto.com has recently announced it has teamed up with Cardlytics, Inc. (NASDAQ: CDLX) to offer cashback rewards to.

Headwaters Capital, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here.

During the last session, Cardlytics Inc. (NASDAQ:CDLX)’s traded shares were 0.43 million, with the beta value of the company hitting 2.34. At the end of the trading day, the stock’s price was $46.82, reflecting an intraday loss of -11.68% or -$6.19. The 52-week high for the CDLX share is $145.00, that puts it down -209.7 … Will Cardlytics Inc. (NASDAQ: CDLX) Stock Boom Or Bust From Here? Read More »

Analysts reiterated a Buy on Cardlytics Inc (NASDAQ: CDLX) post Q4 results. Craig-Hallum analyst Jason Kreyer lowered the firm's price target on Cardlytics from $100 to $70 (15% upside) and kept

Cardlytics <> reports top-line growth of 34%. The company exceeded the consensus mark in Q4.Billings revenue grew 42.6% Y/Y to $133.97M.Adjusted contribution up 48.5% Y/Y…

Analysts reiterated a Buy on Cardlytics Inc (NASDAQ: CDLX) post Q4 results. Craig-Hallum analyst Jason Kreyer lowered the firm's price target on Cardlytics from $100 to $70 (15% upside) and kept

CDLX earnings call for the period ending December 31, 2021.

CDLX earnings call for the period ending December 31, 2021.